Edition:
United Kingdom

People: Shanghai Fosun Pharmaceutical Group Co Ltd (2196.HK)

2196.HK on Hong Kong Stock

23.40HKD
24 May 2019
Change (% chg)

HK$0.35 (+1.52%)
Prev Close
HK$23.05
Open
HK$23.10
Day's High
HK$23.60
Day's Low
HK$22.85
Volume
1,977,500
Avg. Vol
3,681,286
52-wk High
HK$51.65
52-wk Low
HK$19.76

Yao, Fang 

Mr. Yao Fang has been serving as Co-Chairman of the Board in Shanghai Fosun Pharmaceutical (Group) Co., Ltd. since June 8, 2016. He was Chief Financial Officer and Executive Deputy General Manager in the Company. He was Assistant General Manager-International Business Headquarter in a Shanghai-based securities company, General Manager in a Shanghai-based asset business company and a Shanghai-based management company, General Manager and Director in a Shanghai-based medicine investment company, Chairman of the Board in a Shanghai-based overseas company, as well as Executive Director in a Shanghai-based industry company.

Basic Compensation

Total Annual Compensation, CNY --
Restricted Stock Award, CNY --
Long-Term Incentive Plans, CNY --
All Other, CNY --
Fiscal Year Total, CNY 8,397,800

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Qiyu Chen

10,489,600

Fang Yao

8,397,800

Yifang Wu

5,992,100

Xiaohui Guan

3,214,700

Yuqing Chen

2,578,200

Aimin Hui

1,097,800
As Of  31 Dec 2017